Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A
Clinical trial NCT02938585 · COMPLETED
Trial details
- NCT number
- NCT02938585
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-12
- Primary completion
- 2018-03-16
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.